RIGLRigel Pharmaceuticals
$42.55
$1.21
(2.77%)
Closed $42.55
$0.50
(1.18%)
After Hours
EarningsAug 4
Mkt Cap$787.26M
Vol462,528.00
Bioventus (BVS) Soars 12.4%: Is Further Upside Left in the Stock?
Bioventus (BVS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) PR Newswire SOUTH SAN FRANCISCO, Calif., July 7, 2026 SOUTH SAN FRANCISCO, Calif., July 7, 2026 /PRNewswire...
PR Newswire
Rigel CMO Lisa Rojkjaer Retires, Alison Hannah Appointed As New CMO
(RTTNews) - Rigel Pharmaceuticals Inc. (RIGL) announced that Lisa Rojkjaer retired as Chief Medical Officer of the company on July 1, 2026, and Alison Hannah was appointed as the new CMO the same day...
Nasdaq News: Markets
Rigel Appoints Board Member Alison L. Hannah, M.D. as Chief Medical Officer
Rigel Appoints Board Member Alison L. Hannah, M.D. as Chief Medical Officer Rigel Appoints Board Member Alison L. Hannah, M.D. as Chief Medical Officer PR Newswire SOUTH SAN FRANCISCO, Calif., July 1, 2026 Dr. Hannah has decades of oncology drug development experience and has served on Rigel's...
PR Newswire
Rigel Announces Closing of Licensing Agreement for VEPPANU (vepdegestrant)
Rigel Announces Closing of Licensing Agreement for VEPPANU (vepdegestrant) Rigel Announces Closing of Licensing Agreement for VEPPANU (vepdegestrant) PR Newswire SOUTH SAN FRANCISCO, Calif., June 16, 2026 SOUTH SAN FRANCISCO, Calif., June 16, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc.(Nasdaq...
PR Newswire
Rigel to Present at the Jefferies Global Healthcare Conference
Rigel to Present at the Jefferies Global Healthcare Conference Rigel to Present at the Jefferies Global Healthcare Conference PR Newswire SOUTH SAN FRANCISCO, Calif., May 27, 2026 SOUTH SAN FRANCISCO, Calif., May 27, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial...
PR Newswire
Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress
Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress PR Newswire SOUTH SAN FRANCISCO, Calif., May 21, 2026 Oral presentation at ASCO Annual Meeting to...
PR Newswire
Rigel to Present at the 2026 RBC Capital Markets Global Healthcare Conference
Rigel to Present at the 2026 RBC Capital Markets Global Healthcare Conference Rigel to Present at the 2026 RBC Capital Markets Global Healthcare Conference PR Newswire SOUTH SAN FRANCISCO, Calif...
PR Newswire
Rigel Pharmaceuticals Inks Breast Cancer Drug Deal With Arvinas, Pfizer
Rigel Pharmaceuticals stock jumps after signing a VEPPANU licensing deal with Arvinas and Pfizer following recent FDA approval.read more...
Benzinga
<
1
2
...
>